Natural Protein Points to New Inflammation Treatment Findings may offer insight to effective treatments for inflammatory diseases, such as rheumatoid arthritis, psoriasis, and multiple sclerosis.Natural Protein Points to New Inflammation Treatment Findings may offer insight to effective treatments for inflammatory diseases, such as rheumatoid arthritis, psoriasis, and multiple sclerosis.Enzyme Links Age-Related Inflammation, Cancer Researchers have shown that an enzyme key to regulating gene expression -- and also an oncogene when mutated -- is critical for the expression of numerous inflammatory compounds that have been implicated in age-related increases in cancer and tissue degeneration. New Biomarker to Assess Stem Cells Developed A research team led by scientists from UCL have found a way to assess the viability of 'manufactured' stem cells known as induced pluripotent stem cells (iPSCs). The team's discovery offers a new way to fast-track screening methods used in stem cell research.Therapy Halts Progression of Lou Gehrig’s Disease Researchers at Oregon State University announced today that they have essentially stopped the progression of amyotrophic lateral sclerosis (ALS), or Lou Gehrig’s disease, for nearly two years in one type of mouse model used to study the disease – allowing the mice to approach their normal lifespan.Crouching Protein, Hidden Enzyme A new study led by scientists at The Scripps Research Institute (TSRI) and the University of California (UC), Berkeley shows how a crucial molecular enzyme starts in a tucked-in somersault position and flips out when it encounters the right target.HIV Protein Manipulates Hundreds of Human Genes Findings search for new or improved treatments for patients with AIDS.First 3-D Vision of Cancer Target This basic research set the grounds for structure-based drug design approaches that could be beneficial for cancer treatments' - Dr. Cyril Dominguez, University of Leicester.New Light Shed on Genetic Regulation A team of scientists has uncovered greater intricacy in protein signaling than was previously understood, shedding new light on the nature of genetic production.Hacking the Programs of Cancer Stem Cells All tumor cells are the offspring of a single, aberrant cell, but they are not all alike.
Detection and Clinical Implications of Circulating Tumor Cells in Cancer Patients Professor Klaus Pantel, University Medical Center Hamburg-Eppendorf, speaking at Molecular Medicine Congress 2013.
Proteomics of Triple-negative Breast Cancer Metodi Metodiev, University of Essex, speaking at Systems Biology Europe 2012
Circulating Tumor Antigens and their Autoantibody Reactivity as Cancer Markers Samir Hanash, Program Head, Fred Hutchinson Cancer Research Center, speaking at CellTech 2013.
Harmonization and Standardization of CNS Biomarkers Rivka Ravid, Royal Dutch Academy of Sciences, speaking at European Lab Automation 2013.
The Development of Stapled Peptides that Modulate the BRCA2-RAD51 Interaction Chiara Valenzano, University of Cambridge, speaking at Discovery Chemistry Congress 2013.
Inhibition of Protein-protein Interactions Using Designed Molecules Andrew Wilson, University of Leeds, speaking at Discovery Chemistry Congress 2013.
Druggability of Dynamic Protein-Protein Interfaces Volkhard Helms, Universitat des Saarlandes, speaking at Discovery Chemistry Congress 2013.
Library Design for Tackling Protein-protein Interactions: The 2P2I Approach Dr Philippe Roche, CNRS, speaking at Discovery Chemistry Congress 2013.
PASylation: the Biological Alternative to PEGylation Uli Binder, XL Protein GmbH, speaking at Discovery Chemistry Congress 2013.